logo
Plus   Neg
Share
Email

Allergan : FDA Oks Juvéderm VOLUMA XC For Mid-Face Injection Via Cannula

Allergan plc (AGN) said that it received U.S. Food and Drug Administration approval for the use of Juvéderm VOLUMA XC, a hyaluronic acid gel dermal filler, with a TSK STERiGLIDE cannula for cheek augmentation to correct age-related volume deficit in the mid-face in adults over 21.

A cannula is a thin, flexible tube with a rounded tip that can serve as an effective delivery system. Use of a cannula allows for injection of Juvéderm VOLUMA XC in the cheek area.

Juvéderm VOLUMA XC was first approved by the FDA in 2013 and is formulated with Allergan's proprietary VYCROSS technology, which blends different molecular weights of hyaluronic acid, contributing to the gel's duration.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Fast-food chain Burger King has tested a new recipe for cow's diet to offer its customers reduced methane emission beef. It partnered with globally renowned scientists to develop and test a new diet for cows, which will help reduce cows' daily methane emissions. The second largest fast food hamburger chain in the world will begin offering the Reduced Methane Emissions Beef Whopper sandwich. The New York Times announced its plans to relocate its Hong Kong-based digital news operation to South Korea's Seoul, amid uncertainty following China's tough national security law for the semi-autonomous city. The news organization cited the possible impact of Beijing's new security law to the city's prospects as a hub for journalism in Asia. Search giant Google, Inc. announced Wednesday that it signed an agreement to invest $4.5 billion or 33,737 crore Indian rupees in India's Jio Platforms Ltd, taking a 7.73 percent stake in the company, pending regulatory review in India. This investment by Google values Jio Platforms at an equity value...
Follow RTT